Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2011
End Date:February 2012

Use our guide to learn which trials are right for you!

An Exploratory Phase 1, Fixed Sequence, Open-Label Study To Assess The Effects Of CP-690,550 On The Kinetics Of Cholesterol Flux Through The High Density Lipoprotein/Reverse Cholesterol Transport Pathway In Patients With Active Rheumatoid Arthritis


The purpose of study is to explore the effect of CP-690,550 (tasocitinib) on cholesterol
metabolism in patients with active rheumatoid arthritis (RA).



We found this trial at
2
sites
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Beckley, West Virginia 25801
?
mi
from
Beckley, WV
Click here to add this to my saved trials